
Retrospective review of experience with sarcomatoid renal cell carcinoma: Multimodality treatment remains an unmet goal
Author(s) -
Kondisetty Gowrinath,
Pallavi Vijay Borkar,
Sandeep Kondisetty,
Appu Thomas
Publication year - 2019
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/ua.ua_106_18
Subject(s) - medicine , log rank test , chemotherapy , retrospective cohort study , proportional hazards model , survival analysis , nephrectomy , renal cell carcinoma , oncology , distant metastasis , metastasis , surgery , cancer , kidney
Sarcomatoid change in Renal cell carcinoma(RCC) is associated with adverse outcomes with median survival of 6 months.